This report describes a comparative study between technetium-99m ethyl cysteinate dimer
(ECD) and 99m Tc-hexamethylpropylene amine oxime (HMPAO) in five neurological …

The purpose of this study was to investigate the differences between technetium-99m ethyl
cysteinate dimer (99m Tc-ECD) and technetium-99m hexamethylpropylene amine oxime …

The kinetic behavior of 99mTc-hexamethylpropyleneamine oxime (HMPAO) in the human
brain was investigated in 11 patients with various brain diseases (176 regions), using …

The lipophilic 99mTc-D, L-hexamethylene-propyleneamine oxime (99mTc-HMPAO) has
been developed for regional cerebral blood flow (rCBF) measurements by single photon …

"" Tc-HMPAO and 99nTc-ECD studies were performed. Methods: Seventeen patients (4
women; 13 men; age 45-89 yr; mean age 71 yr) with various neurological diseases, except …

The pharmacokinetics and quality of planar and SPECT brain imaging of two 99mTc-labeled
brain perfusion agents, d, l-hexamethyl propylene amine oxime (HMPAO) and ethyl …

Arterial radioactivity content after the intravenous administration of HMPAO in seven human
subjects was analyzed. Arterial sampling of 99mTc-HMPAO was performed on each subject …

Technetium-99m-HMPAO and"" Tc-ECD have been used for regional cerebral blood flow
(rCBF) studies using SPECT. However, details of the normal perfusion patterns of these …

To develop non-invasive regional cerebral blood flow (rCBF) measurements using
technetium-99m ethyl cysteinate dimer (99m Tc-ECD) and single-photon emission …

Cerebral blood flow (CBF) has been quantified non-invasively using the brain perfusion
index (BPI) determined from radionuclide angiographic data generated by technetium-99m …